Stay updated with breaking news from Cell Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
<p>A new study led by researchers at UChicago Medicine and Indiana University suggests that an existing drug could be repurposed to treat type 1 diabetes, potentially reducing dependence on insulin.</p>
Type 1 diabetes is an autoimmune disease that causes the body's immune system to attack and destroy insulin-producing beta cells in the pancreas. Traditional management of type 1 diabetes has primarily involved replacing the missing insulin with injections which, though effective, can be expensive and burdensome.
In the PROTECT trial, teplizumab preserved β-cell function in newly diagnosed type 1 diabetes patients, slowing the decline of C-peptide levels, but key secondary endpoints, such as time in range and HbA1c, showed numerical trends without statistical significance.
New research indicates that the earliest signs of Parkinson's disease are different than what was previously believed.
PCOS and its complications can make weight loss challenging. Still, the diet and lifestyle tips show you how to lose weight with PCOS 2023.